MedPath

Progesterone

Progesterone Capsules

Approved
Approval ID

96c59a1c-d562-46dd-868b-b2decdfef319

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 28, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Progesterone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-6835
Application NumberANDA205229
Product Classification
M
Marketing Category
C73584
G
Generic Name
Progesterone
Product Specifications
Route of AdministrationORAL
Effective DateApril 12, 2021
FDA Product Classification

INGREDIENTS (7)

PROGESTERONEActive
Quantity: 100 mg in 1 1
Code: 4G7DS2Q64Y
Classification: ACTIB
PEANUT OILInactive
Code: 5TL50QU0W4
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
LECITHIN, SOYBEANInactive
Code: 1DI56QDM62
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MEDIUM-CHAIN TRIGLYCERIDESInactive
Code: C9H2L21V7U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Progesterone - FDA Drug Approval Details